Cargando…

Renoprotective effect of tolvaptan in patients with new‐onset acute heart failure

AIMS: Although tolvaptan has been reported to prevent worsening renal function (WRF) in patients with advanced acute heart failure (AHF), evidence regarding the effect of tolvaptan on renal function in patients with new‐onset AHF is not available. This study aimed to investigate the renoprotective e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kin, Hiromi, Matsumura, Koichiro, Yamamoto, Yoshihiro, Fujii, Kenichi, Otagaki, Munemitsu, Takahashi, Hiroki, Park, Haengnam, Yoshioka, Kei, Yokoi, Mitsuru, Sugiura, Tetsuro, Shiojima, Ichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373889/ https://www.ncbi.nlm.nih.gov/pubmed/32383323 http://dx.doi.org/10.1002/ehf2.12738

Ejemplares similares

Clinical Implication of Coronary Artery Calcium Score in Survivors of Out-of-Hospital Cardiac Arrest
por: Matsumura, Koichiro, et al.
Publicado: (2019)

Shortened red blood cell age in patients with end-stage renal disease who were receiving haemodialysis: a cross-sectional study
por: Matsumura, Koichiro, et al.
Publicado: (2020)

Differential effect of malnutrition between patients hospitalized with new‐onset heart failure and worsening of chronic heart failure
por: Matsumura, Koichiro, et al.
Publicado: (2021)

Prognostic Value of Psoas Muscle Mass Index in Patients With Non‒ST‐Segment‒Elevation Myocardial Infarction: A Prospective Observational Study
por: Matsumoto, Hiroshi, et al.
Publicado: (2020)

Loss of skeletal muscle mass predicts cardiac death in heart failure with a preserved ejection fraction but not heart failure with a reduced ejection fraction
por: Matsumura, Koichiro, et al.
Publicado: (2020)

Renoprotection by long‐term low‐dose tolvaptan in patients with heart failure and hyponatremia
por: Oka, Tatsufumi, et al.
Publicado: (2021)

Temporal Change in Renoprotective Effect of Tolvaptan on Patients with Heart Failure: AURORA Study
por: Nishino, Masami, et al.
Publicado: (2022)

Renoprotective Benefit of Tolvaptan in Acute Decompensated Heart Failure Patients With Loop Diuretic-Resistant Status
por: Yamamoto, Tomohiko, et al.
Publicado: (2019)

Evaluation of recombinant human erythropoietin responsiveness by measuring erythrocyte creatine content in haemodialysis patients
por: Hasegawa, Shun, et al.
Publicado: (2021)

Effect of Exercise Training on Body Temperature in the Elderly: A Retrospective Cohort Study
por: Matsumura, Koichiro, et al.
Publicado: (2021)

Diagnostic accuracy and clinical usefulness of erythrocyte creatine content to predict the improvement of anaemia in patients receiving maintenance haemodialysis
por: Hayashi, Ohki, et al.
Publicado: (2023)

Tolvaptan
por: Rangarajan, Bharath, et al.
Publicado: (2014)

Effect of sodium glucose cotransporter 2 inhibitors on cardiac function and cardiovascular outcome: a systematic review
por: Matsumura, Koichiro, et al.
Publicado: (2019)

Long-Term Outcomes of Longitudinal Efficacy Study With Tolvaptan in ADPKD
por: Higashihara, Eiji, et al.
Publicado: (2021)

Renoprotective Effect of the Mineralocorticoid Receptor Antagonist Esaxerenone
por: Oshima, Akira, et al.
Publicado: (2021)

Potential effect of tolvaptan on polycystic liver disease for patients with ADPKD meeting the Japanese criteria of tolvaptan use
por: Mizuno, Hiroki, et al.
Publicado: (2022)

Long-Term Tolvaptan Treatment in Refractory Heart Failure
por: Imamura, Teruhiko, et al.
Publicado: (2019)

Tolvaptan- and Tolvaptan-Metabolite-Responsive T Cells in Patients with Drug-Induced Liver Injury
por: Gibson, Andrew, et al.
Publicado: (2020)

Antagomir-92a impregnated gelatin hydrogel microsphere sheet enhances cardiac regeneration after myocardial infarction in rats()
por: Fujita, Masanori, et al.
Publicado: (2016)

Renoprotective effects of garlic
por: Nasri, Hamid
Publicado: (2013)

Renoprotective effects of metformin
por: Nasri, Running Hamid
Publicado: (2013)

The renoprotective effects of sulodexide
por: Olde Engberink, Rik HG, et al.
Publicado: (2016)

Tolvaptan for the Treatment of Enlarged Polycystic Liver Disease
por: Mizuno, Hiroki, et al.
Publicado: (2017)

Tolvaptan, hyponatremia, and heart failure
por: Zmily, Hammam D, et al.
Publicado: (2011)

Tolvaptan for the Treatment of Refractory Ascites
por: Kurosaki, Masayuki, et al.
Publicado: (2016)

Renoprotective effects of telmisartan after unilateral renal ablation in rats
por: Matsuo, Tomohiro, et al.
Publicado: (2013)

Role of Liver Transplantation in Tolvaptan-Associated Acute Liver Failure
por: Endo, Mayumi, et al.
Publicado: (2019)

Renoprotective Action of a Matrix Metalloproteinase Inhibitor in Progressive Mesangioproliferative Nephritis
por: Kuroda, Takayuki, et al.
Publicado: (2012)

Renoprotection and the Bardoxolone Methyl Story – Is This the Right Way Forward? A Novel View of Renoprotection in CKD Trials: A New Classification Scheme for Renoprotective Agents
por: Onuigbo, Macaulay
Publicado: (2013)

Renoprotective effects of green tea
por: Hajian, Shabnam
Publicado: (2013)

Possible renoprotective effects of dabigatran
por: Karahan, Oğuz
Publicado: (2015)

Early renoprotection by anemia correction
por: Kuriyama, Satoru
Publicado: (2018)

Mineralocorticoid receptor blockade for renoprotection
por: Cha, Dae Ryong
Publicado: (2018)

Tolvaptan and its potential in the treatment of hyponatremia
por: Dixon, Megan B, et al.
Publicado: (2008)

V2 Receptor Antagonist; Tolvaptan
por: Yi, Joo-Hark, et al.
Publicado: (2011)

Predictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis
por: Iwamoto, Takuya, et al.
Publicado: (2016)

The management of polycystic liver disease by tolvaptan
por: Takenaka, Tsuneo, et al.
Publicado: (2020)

Tolvaptan for the Treatment of Elephantiasis Nostras Verrucosa
por: Eda, Yuko, et al.
Publicado: (2019)

Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus
por: Esaki, Hiroki, et al.
Publicado: (2017)

Comprehensive renoprotective effects of ipragliflozin on early diabetic nephropathy in mice
por: Kamezaki, Michitsugu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ptjlpo6jsed23apn8r2l08avrk